A61P 11/16
Central respiratory analeptics
A61P11/16 (Central respiratory analeptics) appears on 987 US grants and 1,513 published applications in this corpus.
Search patents in A61P- Granted patents
- 987
- Published applications
- 1,513
- Assignees
- 567
- Inventors
- 3,379
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 2 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 6 | 0 |
| 1996 | 5 | 0 |
| 1997 | 6 | 0 |
| 1998 | 6 | 0 |
| 1999 | 15 | 0 |
| 2000 | 9 | 0 |
| 2001 | 11 | 4 |
| 2002 | 23 | 23 |
| 2003 | 22 | 37 |
| 2004 | 24 | 83 |
| 2005 | 19 | 74 |
| 2006 | 27 | 79 |
| 2007 | 27 | 73 |
| 2008 | 35 | 111 |
| 2009 | 51 | 113 |
| 2010 | 75 | 172 |
| 2011 | 75 | 97 |
| 2012 | 68 | 90 |
| 2013 | 81 | 77 |
| 2014 | 76 | 99 |
| 2015 | 67 | 63 |
| 2016 | 53 | 71 |
| 2017 | 43 | 53 |
| 2018 | 32 | 32 |
| 2019 | 23 | 33 |
| 2020 | 33 | 31 |
| 2021 | 15 | 28 |
| 2022 | 15 | 16 |
| 2023 | 9 | 17 |
| 2024 | 4 | 15 |
| 2025 | 5 | 10 |
| 2026 | 6 | 12 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- N-(pyridin-2-yl)-6,7,8,9-tetrahydro-5h-5,8-epiminocyclohepta[c]pyridine-10-carboxamide derivatives and similar compounds as GPR65 modulators for the treatment of cancer9 Jun 2026US 12,649,744 B2Pathios Therapeutics Limited
- Opioid receptor antagonists2 Jun 2026US 12,643,907 B2University of Southern California
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Modified bovine G-CSF polypeptides and their uses28 Apr 2026US 12,612,440 B2Ambrx, Inc.
- Treatment of ARDS and other conditions caused by acutely elevated cytokine levels and post ARDS chronic cytokine production using inhaled anesthetics14 Apr 2026US 12,599,625 B2Penland Foundation
- Thiol-based compounds and compositions and uses thereof3 Sep 2026US 2026/0256723 A1
- Fc region variant27 Aug 2026US 2026/0250360 A1Chugai Seiyaku Kabushiki Kaisha
- Aminosteroids for the Treatment of a PTP1B Associated Disease20 Aug 2026US 2026/0242409 A1Depymed, Inc.
- Oxygen enema composition, enema device, and method for producing oxygen enema composition23 Jul 2026US 2026/0207658 A1MediScience Espoir Inc.
- Compositions comprising oxytocin and methods of treating opioid overdose23 Jul 2026US 2026/0207703 A1The George Washington University
Most cited
By later US patents
- Human antibodies that bind human TNF.alpha.451US 6,090,382 ABASF SE · 2000
- Human antibodies that bind human TNFα308US 6,258,562 B1BASF SE · 2001
- Devices, systems, and methods to fixate tissue within the regions of body, such as the pharyngeal conduit230US 7,360,542 B2Apneon, Inc. · 2008
- Human antibodies that bind human TNFa212US 6,509,015 B1BASF SE · 2003
- Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta180US 7,932,260 B2ICOS Corporation · 2011